← The SEC Ephemeris: the whole map
Novitium Pharma LLC Hydroxychloroquine Sulfate
In the graph: all 1 documents (2 pages).
- Application
- NDA 214581
- Ticker
- Novitium Pharma LLC
- Product
- Hydroxychloroquine Sulfate
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- February 12, 2021
From FDA letters and SEC filings. Not investment or medical advice.